These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 8592224)
1. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. Kassell NF; Haley EC; Apperson-Hansen C; Alves WM J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304 [TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. Lanzino G; Kassell NF J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603 [TBL] [Abstract][Full Text] [Related]
6. [Indications for steroid and tirilazad treatment in patients with subarachnoid hemorrhage]. Tommasino C; Picozzi P Minerva Anestesiol; 1998 May; 64(5):225-7. PubMed ID: 9773664 [TBL] [Abstract][Full Text] [Related]
7. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Jang YG; Ilodigwe D; Macdonald RL Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661 [TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Torner JC J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326 [TBL] [Abstract][Full Text] [Related]
9. Economic analysis of tirilazad mesylate for aneurysmal subarachnoid hemorrhage. Economic evaluation of a phase III clinical trial in Europe and Australia. Glick H; Willke R; Polsky D; Llana T; Alves WM; Kassell N; Schulman K Int J Technol Assess Health Care; 1998; 14(1):145-60. PubMed ID: 9509802 [TBL] [Abstract][Full Text] [Related]
10. Tirilazad for aneurysmal subarachnoid haemorrhage. Zhang S; Wang L; Liu M; Wu B Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088 [TBL] [Abstract][Full Text] [Related]
11. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. Marshall LF; Maas AI; Marshall SB; Bricolo A; Fearnside M; Iannotti F; Klauber MR; Lagarrigue J; Lobato R; Persson L; Pickard JD; Piek J; Servadei F; Wellis GN; Morris GF; Means ED; Musch B J Neurosurg; 1998 Oct; 89(4):519-25. PubMed ID: 9761043 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators. Stroke; 1996 Sep; 27(9):1453-8. PubMed ID: 8784112 [TBL] [Abstract][Full Text] [Related]
13. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). STIPAS Investigators Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754 [TBL] [Abstract][Full Text] [Related]
14. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. Siironen J; Juvela S; Varis J; Porras M; Poussa K; Ilveskero S; Hernesniemi J; Lassila R J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720 [TBL] [Abstract][Full Text] [Related]
15. Too little, too late: does tirilazad mesylate reduce fatigue after subarachnoid hemorrhage? Ogden JA; Mee EW; Utley T Neurosurgery; 1998 Oct; 43(4):782-7. PubMed ID: 9766304 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. Macdonald RL; Rosengart A; Huo D; Karrison T J Neurosurg; 2003 Oct; 99(4):644-52. PubMed ID: 14567598 [TBL] [Abstract][Full Text] [Related]
17. Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage. Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T Stroke; 1999 Feb; 30(2):450-5; discussion 455-6. PubMed ID: 9933286 [TBL] [Abstract][Full Text] [Related]
18. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249 [TBL] [Abstract][Full Text] [Related]
19. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: results of a multicenter, placebo-controlled double-blind trial. Asano T; Takakura K; Sano K; Kikuchi H; Nagai H; Saito I; Tamura A; Ochiai C; Sasaki T J Neurosurg; 1996 May; 84(5):792-803. PubMed ID: 8622153 [TBL] [Abstract][Full Text] [Related]
20. Intraventricular hemorrhage from ruptured aneurysm: clinical characteristics, complications, and outcomes in a large, prospective, multicenter study population. Rosen DS; Macdonald RL; Huo D; Goldenberg FD; Novakovic RL; Frank JI; Rosengart AJ J Neurosurg; 2007 Aug; 107(2):261-5. PubMed ID: 17695378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]